A research tem has made significant forward progress in establishing a cure for type 1 diabetes amongst mice, and the first steps towards a human trial could soon become a reality.
Type 1 diabetes is a lesser known and potentially more serious form of diabetes. Type 1 diabetics have to administer insulin on a daily basis to keep their blood sugar levels stable. Type 1 is autoimmune, and usually emerges in childhood.
The new treatment, developed by experts at the Transplant Research Centre, Beth Israel Deaconess Medical Centre, involves three drugs. The report was published in this week’s edition of the Proceedings of the National Academy of Sciences.
Type 1 was successfully reversed amongst mice, and a drug course lasting four weeks restored normal blood sugar function.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.